Peri-operative Effect of EPO Combined with Iron in Total Hip Arthroplasty: A prospective Randomized, Controlled Trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022790

Enrollment

Unknown

Registered

2019-04-26

Start date

2019-04-26

Completion date

Unknown

Last updated

2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total hip arthroplasty

Interventions

Experiment:Perioperatively EPO+Iron

Control Group :Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Aged 18 to 85 years, Undertake total knee arthroplasty; preoperative HB level 90-130(g/L); Informed consent is available.

Exclusion criteria

Exclusion criteria: Patients diagnose Rheumatoid arthritis; total knee arthroplasty revision; coagulation; history of blood transfusion within 3 months.

Design outcomes

Primary

Measure	Time frame
Hemoglobin;HCT;Function outcomes;	—

Secondary

Measure	Time frame
Hospital Stay;Complication;	—

Countries

China

Contacts

Public ContactZongke Zhou

West China Hospital, Sichuan University

tqf6698508@163.com+86 18096306849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026